Associate Editor, Ophthalmology Times
AAO 2023: FundamentalVR and AAO team up for pediatric ophthalmic training VR program
November 3rd 2023The collaboration, fueled by a $5 million donation from Knights Templar Eye Foundation (KTEF), will introduce a free and open VR simulation program for ophthalmologists and trainees worldwide.
Read More
STAAR Surgical celebrates 30th anniversary of Implantable Collamer Lens (ICL).
October 17th 2023EVO ICLs, which evolved from early generation ICLs, offer a lens-based alternative for the correction/reduction of refractive error in people who currently use glasses and/or contact lenses for vision correction.
Read More
Aldeyra Therapeutics faces stock plunge and potential FDA setback for reproxalap approval
October 16th 2023Aldeyra Therapeutics encounters a significant setback, with its stock value plummeting nearly 70%. The FDA indicates a potential Complete Response Letter (CRL) for reproxalap, a dry eye treatment, despite a scheduled Prescription Drug User Fee Act (PDUFA) date of November 23, 2023.
Read More
New study reveals improved eye health could boost US economy by $50.4 billion annually
October 12th 2023A groundbreaking study conducted by the International Agency for the Prevention of Blindness (IAPB) and Kevin Frick, PhD, from Johns Hopkins University reveals that prioritizing better eye health could inject a staggering $50.4 billion annually into the US economy.
Read More
Arctic Vision completes enrollment in Phase 3 trial for uveitic macular edema treatment ARCATUS
October 7th 2023This milestone was announced by Clearside Biomedical, Inc., Arctic Vision's partner. ARCATUS, also known as XIPERE®, utilizes a revolutionary suprachoroidal delivery platform, offering new hope to patients in China suffering from this vision-threatening condition.
Read More
ZEISS Medical Technology and Boehringer Ingelheim announce long-term collaboration
October 6th 2023The collaboration will drive an effort to develop predictive analytics to enable early detection of eye diseases and more personalized treatments to prevent vision loss for people with serious eye diseases.
Read More
Eyecbetter announces Amy Dixon, PLY (Paralympian), as new Director of Patient Advocacy
September 23rd 2023As a gold medalist with profound vision loss, she will lead advocacy efforts for people with glaucoma that are designed to empower patients to participate actively in their glaucoma treatment journey
Read More